한빛사논문 | BRIC

임영석 님의 논문 목록

울산대학교 의과대학

CV File 220 kb

Baseline viral load and on-treatment hepatocellular carcinoma risk in chronic hepatitis B: A multinational cohort study
- Clin. Gastroenterol. Hepatol., Aug 22 2024, S1542-3565(24)00763-8 | https://doi.org/10.1016/j.cgh.2024.07.031
- 2024-08
- 의약학
- 한빛사논문
Non-Linear Association Between Liver Fibrosis Scores and Viral Load in Patients with Chronic Hepatitis B
- Clin. Mol. Hepatol., Jul 19 2024, | https://doi.org/10.3350/cmh.2024.0252
- 2024-07
- 의약학
- 한빛사논문
- 임영석(울산대학교 의과대학)
Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study
- Lancet Gastroenterol. Hepatol., Jun 17 2024, S2468-1253(24)00096-7 | https://doi.org/10.1016/S2468-1253(24)00096-7
- 2024-06
- 의약학
- 한빛사논문
Chronic Hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients
- Hepatology, Jan 24 2024, | https://doi.org/10.1097/HEP.0000000000000752
- 2024-01
- 의약학
- 한빛사논문
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
- Gut, Oct 09 2023, gutjnl-2023-330225 | https://doi.org/10.1136/gutjnl-2023-330225
- 2023-10
- 의약학
- 한빛사논문
Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis
- J. Hepatol., 2022 Dec 23;S0168-8278(22)03459-6 | https://doi.org/10.1016/j.jhep.2022.12.007
- 2022-12
- 의약학
- 한빛사논문
Tenofovir Alafenamide for Multiple Drug-Resistant Chronic Hepatitis B: A 3-Year Clinical Trial
- Clin. Gastroenterol. Hepatol., 2023 Jan 11;S1542-3565(22)01183-1 | https://doi.org/10.1016/j.cgh.2022.12.016
- 2023-01
- 의약학
- 한빛사논문
- 임영석(울산대학교 의과대학)
Hepatitis B virus treatment and hepatocellular carcinoma-controversies and approaches to consensus
- Liver Cancer, December 2022;11(6):497-510 | https://doi.org/10.1159/000525518
- 2022-12
- 의약학
- 한빛사논문
Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply
- J. Clin. Invest., Published August 1, 2022;132(15):e161425. | https://doi.org/10.1172/JCI161425
- 2022-08
- 의약학
- 한빛사논문
Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
- J. Clin. Invest., 2022 Mar 31;e154833 | https://doi.org/10.1172/JCI154833
- 2022-03
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기